Article Dans Une Revue Chemical Science Année : 2024

A cancer immunoprofiling strategy using mass spectrometry coupled with bioorthogonal cleavage

Résumé

The accurate quantification of biomarkers is paramount in modern medicine, particularly in cancer where precise diagnosis is imperative for targeted therapy selection. In this paper we described a multiplexed analysis diagnostic approach based on cleavable MS-tagged antibodies. The technology uses MS-tag isotopologues and the sydnonimine-cyclooctyne click-and-release bioorthogonal reaction. In a proof of concept study, we demonstrated the potential of this approach for cancer cell immunoprofiling in culture cells, tissues and in vivo as well, thereby unveiling promising diagnostic avenues.

Domaines

Fichier principal
Vignette du fichier
d4sc04471a.pdf (3.11 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-05032431 , version 1 (13-04-2025)

Licence

Identifiants

Citer

Maxime Ribéraud, Estelle Porret, Alain Pruvost, Frédéric Theodoro, Anvi Laëtitia Nguyen, et al.. A cancer immunoprofiling strategy using mass spectrometry coupled with bioorthogonal cleavage. Chemical Science, 2024, 15 (45), pp.18825-18831. ⟨10.1039/d4sc04471a⟩. ⟨hal-05032431⟩
53 Consultations
63 Téléchargements

Altmetric

Partager

  • More